LLY

900.42

-0.89%↓

UNH

598.87

+0.84%↑

NVO

129.77

-1.66%↓

JNJ

167.37

+0.45%↑

ABBV

199.41

+1.61%↑

LLY

900.42

-0.89%↓

UNH

598.87

+0.84%↑

NVO

129.77

-1.66%↓

JNJ

167.37

+0.45%↑

ABBV

199.41

+1.61%↑

LLY

900.42

-0.89%↓

UNH

598.87

+0.84%↑

NVO

129.77

-1.66%↓

JNJ

167.37

+0.45%↑

ABBV

199.41

+1.61%↑

LLY

900.42

-0.89%↓

UNH

598.87

+0.84%↑

NVO

129.77

-1.66%↓

JNJ

167.37

+0.45%↑

ABBV

199.41

+1.61%↑

LLY

900.42

-0.89%↓

UNH

598.87

+0.84%↑

NVO

129.77

-1.66%↓

JNJ

167.37

+0.45%↑

ABBV

199.41

+1.61%↑

Inicio・Lista de Acciones・Adverum Biotechnologies Inc

Adverum Biotechnologies Inc

Abierto

Sector Salud

6.91 0.44

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

6.84

Máximo

6.98

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+343.79 upside

Noticias sobre sentimiento de mercado

By Acuity

100%

335 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

N/A / 1.61 Soporte y Resistencia

Adverum Biotechnologies Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

9 sept 2024, 23:02 UTC

Principales Noticias

Ganancias

U.S. Dividends Grew 9% in the Second Quarter. Meta and Alphabet Gave a Boost. -- Barrons.com

9 sept 2024, 23:00 UTC

Adquisiciones, fusiones, absorciones

U.S. Presses Its Antitrust Cases Against Google, Tapestry -- Barrons.com

9 sept 2024, 22:27 UTC

Charlas de Mercado

U.S. Solar-Panel Manufacturing Capacity Rises Four Fold in Two Years -- Market Talk

9 sept 2024, 22:19 UTC

Principales Noticias

Ganancias

Goldman CEO Solomon Expects Trading Revenue Drop in Third Quarter -- Barrons.com

9 sept 2024, 21:22 UTC

Principales Noticias

Don't Count Nvidia and the Rest of the Mag 7 Out Just Yet -- Barrons.com

9 sept 2024, 21:01 UTC

Principales Noticias

Incoming Starbucks CEO's Tall Order: Calming Anxious Employees -- Update

9 sept 2024, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

9 sept 2024, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

9 sept 2024, 20:48 UTC

Adquisiciones, fusiones, absorciones

IBM to Acquire Accelalpha, an Oracle Consultancy

9 sept 2024, 20:44 UTC

Principales Noticias

Ganancias

Oracle 1Q Profit, Rev Rise Amid Additional AI Contract Wins

9 sept 2024, 20:40 UTC

Principales Noticias

Dow, S&P 500 Rise More Than 1% to Start the Week -- WSJ

9 sept 2024, 20:32 UTC

Adquisiciones, fusiones, absorciones

IBM to Acquire Accelalpha, Leading Oracle Consultancy >IBM

9 sept 2024, 20:32 UTC

Adquisiciones, fusiones, absorciones

IBM: Accelalpha Will Join IBM Consulting >IBM

9 sept 2024, 20:32 UTC

Adquisiciones, fusiones, absorciones

IBM: Acquisition Expands IBM's Oracle Consulting Expertise in Supply Chain and Logistics, Finance, Enterprise Performance Management

9 sept 2024, 20:32 UTC

Adquisiciones, fusiones, absorciones

IBM Didn't Disclose Financial Details of Accelalpha Acquisition >IBM

9 sept 2024, 20:31 UTC

Principales Noticias

DirecTV Subscribers Might Miss 'Monday Night Football' as Fight With Disney Drags On -- WSJ

9 sept 2024, 20:31 UTC

Principales Noticias

Dow, S&P 500 Rise More Than 1% to Start the Week -- WSJ

9 sept 2024, 20:30 UTC

Principales Noticias

Norfolk Southern CEO Expected to Depart Amid Board Probe -- WSJ

9 sept 2024, 20:30 UTC

Adquisiciones, fusiones, absorciones

IBM to Acquire Accelalpha, Leading Oracle Consultancy

9 sept 2024, 20:30 UTC

Adquisiciones, fusiones, absorciones

IBM To Acquire Accelalpha, Leading Oracle Consultancy >IBM

9 sept 2024, 20:22 UTC

Ganancias

Oracle Stock Jumps On Earnings Beat, Amazon Partnership -- IBD

9 sept 2024, 20:17 UTC

Ganancias

Oracle Earnings Beat Estimates. The Stock Is Rising. -- Barrons.com

9 sept 2024, 20:06 UTC

Ganancias

Oracle: Strong Contract Backlog to Increase Revenue Growth Throughout FY25 >ORCL

9 sept 2024, 20:05 UTC

Ganancias

Oracle 1Q Hardware Revenue $655M >ORCL

9 sept 2024, 20:05 UTC

Ganancias

Oracle 1Q Rev $13.31B >ORCL

9 sept 2024, 20:05 UTC

Ganancias

Oracle 1Q Cloud License and On-Premise License Revenue $870M >ORCL

9 sept 2024, 20:05 UTC

Ganancias

Oracle 1Q Services Revenue $1.26B >ORCL

9 sept 2024, 20:05 UTC

Ganancias

Oracle 1Q Cloud Services and License Support Revenue $10.52B >ORCL

9 sept 2024, 20:05 UTC

Ganancias

Oracle 1Q Adj EPS $1.39 >ORCL

9 sept 2024, 20:05 UTC

Ganancias

Oracle 1Q Net $2.9B >ORCL

Comparación entre iguales

Cambio de precio

Adverum Biotechnologies Inc Esperado

Precio Objetivo

By TipRanks

343.79% repunte

Estimación a 12 meses

Media 30 USD 343.79%

Máximo 40 USD

Mínimo 12 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Adverum Biotechnologies Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

7 ratings

Comprar

Mantener

Vender

De acuerdo con 7 analistas que ofrecen calificaciones bursátiles a para Adverum Biotechnologies Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

N/A / 1.61Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bullish.

Sentimiento

By Acuity

335 / 365 Clasificación en Salud

Otras acciones del sector

LLY

Eli Lilly and Co.

900.42

↓-0.89%

UNH

UnitedHealth Group Inc

598.87

↑ +0.84%

NVO

Novo Nordisk A-S

129.77

↓-1.66%

JNJ

Johnson and Johnson

167.37

↑ +0.45%

ABBV

AbbVie Inc

199.41

↑ +1.61%

Adverum Biotechnologies Inc

Resumen

Variación precio

Recomendaciones

Noticias sobre sentimiento de mercado

Puntuación técnica

Adverum Biotechnologies Inc Gráfico

Noticias Relacionadas

Comparación entre iguales

Adverum Biotechnologies Inc Esperado

Precio Objetivo

Consenso

Puntuación técnica

Sentimiento

Otras acciones del sector